3 results
Approved WMOPending
The primary objective of the trial is to demonstrate superiority of Pergoveris® versus GONAL-f® in poorovarian response (POR) patients defined according to modified criteria set forth by the European Society of Human Reproduction and Embryology (…
Approved WMOCompleted
PrimaryThe objective of the study is to investigate the safety and tolerability of the partial adenosine A1 agonist BAY 1067197 on top of standard therapy in patients with chronic systolic heart failure.SecundaryPharmacodynamische en hemodynamische…
Approved WMORecruiting
Primary objective: * Determine the feasibility of using 18F-PSMA PET/CT for visualization of GBM.Secondary objectives:* Correlate PSMA RNA and protein expression with 18F-PSMA PET/CT uptake.